12/15-lipoxygenase orchestrates murine wound healing via PPARγ-activating oxylipins acting holistically to dampen inflammation

C Christopher P. Thomas (School of Pharmacy and Pharmaceutical Sciences, Cardiff University) V Victoria J. Tyrrell (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) J James J. Burston (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) S Sam R. C. Johnson (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) M Maceler Aldrovandi (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) J Jorge Alvarez-Jarreta (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) R Rossa Inglis (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) A Adam Leonard (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) L Lydia Fice (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) J Jeremie Costales (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) A Antonio Vidal-Puig (Centro de Investigacion Principe Felipe, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)) M Majd Protty (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) C Carol Guy (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) R Robert Andrews (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) B Barbara Szomolay (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) B Ben C. Cossins (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) A Ana Cardus Figueras (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) S Stefania Carobbio (Centro de Investigacion Principe Felipe, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)) S Simon A. Jones (Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University) V Valerie B. O’Donnell

Abstract

12/15-lipoxygenase (12/15-LOX, Alox15 ) generates bioactive oxygenated lipids during inflammation, however its homeostatic role(s) in normal healing are unclear. Here, the role of 12/15-LOX in resolving skin wounds was elucidated, focusing on how its lipids act together in physiologically relevant amounts. In mice, wounding caused acute appearance of 12/15-LOX-expressing macrophages and stem cells, coupled to early generation of ~12 monohydroxy-oxylipins and enzymatically oxidized phospholipids (eoxPL). Alox15 deletion increased collagen deposition, stem cell/fibroblast proliferation, IL6/pSTAT3, pSMAD3, and interferon (IFN)-γ levels. Conversely, CD206 expression, F480+ cells, and MMP9 and MMP2 activities were reduced. Alox15 −/− skin was deficient in PPARγ/adiponectin activity. Furthermore, while pro-inflammatory genes were upregulated as normal during wounding, many including Il6, Il1b, ccl4, Cd14, Cd274, Clec4d, Clec4e, Csf3, Cxcl2, and miR-21 failed to revert to baseline during healing, indicating disruption of PPARγ’s anti-inflammatory brake on NLRP3/inflammasome and TGF-β signaling. Reconstituting Alox15 −/− wounds with a physiological mixture of Alox15 -derived primary oxylipins generated by healing wounds restored MMP and dampened collagen deposition. The oxylipin mixture activated the PPARγ response element in vitro, while in vivo, its coactivator, Helz2 , was significantly upregulated as well as several fatty acid and prostaglandin PPARγ ligands. Additional inflammatory and proliferative gene networks impacted by Alox15 −/− included Elf4, Cebpb , and Tcf3. In summary, 12/15-LOX generates abundant monohydroxy oxylipins that act together via PPARγ. The identification of multiple gene alterations reveals several targets for treating nonhealing wounds. Our studies demonstrate that 12/15-LOX oxylipins act in concert, dampening inflammation in vivo, revealing the need to consider lipid signaling holistically.

Article Details

Volume / Issue Vol. 122, Issue 36
Published September 09, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (20)

C

Christopher P. Thomas

School of Pharmacy and Pharmaceutical Sciences, Cardiff University

V

Victoria J. Tyrrell

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

J

James J. Burston

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

S

Sam R. C. Johnson

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

M

Maceler Aldrovandi

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

J

Jorge Alvarez-Jarreta

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

R

Rossa Inglis

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

A

Adam Leonard

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

L

Lydia Fice

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

J

Jeremie Costales

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

A

Antonio Vidal-Puig

Centro de Investigacion Principe Felipe, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)

M

Majd Protty

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

C

Carol Guy

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

R

Robert Andrews

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

B

Barbara Szomolay

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

B

Ben C. Cossins

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

A

Ana Cardus Figueras

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

S

Stefania Carobbio

Centro de Investigacion Principe Felipe, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)

S

Simon A. Jones

Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University

V

Valerie B. O’Donnell